- Home
- BANC vs CNTA Comparison
BANC vs CNTA Comparison
Compare BANC & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BANC
- CNTA
- Stock Information
- Founded
- BANC 1941
- CNTA 2020
- Country
- BANC United States
- CNTA United Kingdom
- Employees
- BANC N/A
- CNTA N/A
- Industry
- BANC Major Banks
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- BANC Finance
- CNTA Health Care
- Exchange
- BANC Nasdaq
- CNTA Nasdaq
- Market Cap
- BANC 2.5B
- CNTA 2.2B
- IPO Year
- BANC N/A
- CNTA 2021
- Fundamental
- Price
- BANC $16.22
- CNTA $16.00
- Analyst Decision
- BANC Buy
- CNTA Strong Buy
- Analyst Count
- BANC 11
- CNTA 7
- Target Price
- BANC $17.36
- CNTA $23.71
- AVG Volume (30 Days)
- BANC 2.8M
- CNTA 463.7K
- Earning Date
- BANC 10-22-2024
- CNTA 11-12-2024
- Dividend Yield
- BANC 2.46%
- CNTA N/A
- EPS Growth
- BANC N/A
- CNTA N/A
- EPS
- BANC N/A
- CNTA N/A
- Revenue
- BANC $412,570,000.00
- CNTA $6,853,000.00
- Revenue This Year
- BANC N/A
- CNTA N/A
- Revenue Next Year
- BANC $10.27
- CNTA N/A
- P/E Ratio
- BANC N/A
- CNTA N/A
- Revenue Growth
- BANC N/A
- CNTA N/A
- 52 Week Low
- BANC $11.36
- CNTA $5.58
- 52 Week High
- BANC $16.92
- CNTA $18.74
- Technical
- Relative Strength Index (RSI)
- BANC 57.84
- CNTA 49.07
- Support Level
- BANC $15.93
- CNTA $15.15
- Resistance Level
- BANC $16.88
- CNTA $18.74
- Average True Range (ATR)
- BANC 0.44
- CNTA 0.88
- MACD
- BANC 0.02
- CNTA 0.10
- Stochastic Oscillator
- BANC 67.21
- CNTA 35.68
About BANC Banc of California Inc.
Banc of California Inc is a financial holding company. It offers banking and financial services. The company's services include banking services, lending services, and private banking services. Its deposit and banking product and service offerings include checking, savings, money market, certificates of deposit, and retirement accounts. Lending activities are focused on providing financing to California's diverse private businesses, entrepreneurs, and communities, and loans are often secured by California commercial and residential real estate. The company has one reportable segment named Commercial banking.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.